Dihydroartemisinin/Piperaquine With Dolutegravir-Based Antiretroviral Therapy Safe During Pregnancy
Researchers conducted a study to assess the pharmacokinetics and effect of dolutegravir-based antiretroviral therapy in combination with dihydroartemisinin/piperaquine in women with HIV infection who were pregnant.